Senior Researcher at University of Szeged, Hungary
Dr. Erzsébet Mernyák is a Hungarian organic chemist whose research bridges synthetic chemistry and pharmaceutical science. With over two decades of academic and research experience, she has made significant contributions to the synthesis of biologically active compounds, particularly in the area of photosensitizers, steroidal derivatives, and fluorescent-labeled molecules. She currently serves as an Assistant Professor at the University of Szeged, Hungary. Her work is widely published in high-impact journals such as the International Journal of Molecular Sciences and European Journal of Pharmaceutical Sciences, often in collaboration with interdisciplinary and international teams. Dr. Mernyák has received multiple prestigious grants and awards that reflect her excellence in both research and education. Recognized for her dedication to student mentorship, she has also earned the “Golden Chalk Prize” from the Faculty of Natural Sciences and Informatics. Her continued innovation and leadership make her a valuable asset to the scientific community in Hungary and beyond.
Professional Profile
Education🎓
Dr. Erzsébet Mernyák’s academic journey is rooted in the prestigious University of Szeged, where she earned her Ph.D. in Chemistry in 2002, specializing in the Organic Chemistry Subprogram of the Doctoral School of Chemistry. Her earlier academic foundation was laid at József Attila University, also in Szeged, where she obtained her M.Sc. in Chemistry in 1999. Her doctoral studies focused on synthetic methodologies and structural analysis of complex organic molecules, setting the stage for a research career that would later explore various branches of pharmaceutical and medicinal chemistry. This solid academic training, particularly in fundamental and applied organic chemistry, has allowed her to develop a robust understanding of both classical and modern techniques in organic synthesis. Her advanced education continues to support her current interdisciplinary research, which often integrates aspects of spectroscopy, molecular pharmacology, and bioorganic chemistry, highlighting her firm grounding in both theory and practical application.
Professional Experience📝
Dr. Mernyák has built a progressive and dedicated academic career at the University of Szeged, starting as a Research Assistant in 2002. Over the years, she has held multiple research-focused positions, including OTKA Postdoctoral Researcher (2005), Research Fellow (2010), and currently, Assistant Professor since 2017. Her career trajectory reflects a sustained commitment to scholarly advancement and innovation in organic chemistry. She has played a central role in various collaborative research projects, many of which resulted in peer-reviewed publications and national conference presentations. In addition to her research duties, she has consistently contributed to teaching and mentoring, which is recognized through student-nominated awards like the “Golden Chalk Prize.” Through these roles, Dr. Mernyák has not only contributed to scientific inquiry but has also helped shape the next generation of chemists. Her experience exemplifies a balanced blend of research excellence, educational leadership, and academic service.
Research Interest🔎
Dr. Erzsébet Mernyák’s research interests lie at the interface of organic synthesis and pharmaceutical applications. She specializes in designing and synthesizing bioactive molecules, such as flavonoid derivatives, steroidal compounds, and photosensitizers with potential therapeutic and diagnostic uses. Her recent focus includes developing BODIPY-based fluorescent dyes and estradiol conjugates for biological imaging and drug delivery systems. Additionally, she explores site-selective functionalization techniques, including C–H and O–H activation, which are crucial in the sustainable modification of complex molecules. Dr. Mernyák is particularly interested in compounds that exhibit anticancer or hormone-regulating properties, bridging synthetic chemistry with medicinal applications. Her interdisciplinary research is often conducted in collaboration with pharmacologists, biochemists, and international researchers. These pursuits not only advance chemical understanding but also have real-world biomedical implications. With a clear focus on innovation and translational potential, her research addresses critical scientific questions in drug design and chemical biology.
Award and Honor🏆
Dr. Mernyák’s outstanding work in research and education has been recognized through numerous national awards and competitive research grants. Notably, she has received the Bolyai János Research Grant twice (2003, 2016), awarded by the Hungarian Academy of Sciences, reflecting her long-term impact and consistency in high-quality research. She was also awarded the Magyary Zoltán Postdoctoral Grant in 2013, further supporting her innovative contributions to organic synthesis. Between 2017 and 2019, she was honored with the New National Excellence Grant three years in a row, a testament to her ongoing relevance and productivity in academic research. In recognition of her teaching and mentorship, she earned the Golden Chalk Prize in both 2017 and 2023. Another major milestone was receiving the Zemplén Géza Award in 2015, a prestigious acknowledgment from the Hungarian Academy of Sciences. These accolades collectively reflect her multidimensional excellence in research, education, and scientific contribution.
Research Skill🔬
Dr. Mernyák brings an advanced and diverse set of research skills to the field of organic and medicinal chemistry. She is proficient in multistep organic synthesis, structure elucidation, and molecular characterization using spectroscopic methods like NMR, UV-Vis, and mass spectrometry. Her skill in designing fluorescent molecular probes and photoactive compounds makes her a valuable contributor to interdisciplinary pharmaceutical research. She has deep expertise in C–H activation techniques, which are cutting-edge strategies in sustainable chemistry for modifying complex molecules. Additionally, she is experienced in collaborating with biologists and pharmacologists to conduct biological evaluations of synthesized compounds, particularly those with antiproliferative or estrogenic activity. Her familiarity with Q1/Q2-ranked journal publishing, research documentation, and conference presentation further showcases her ability to communicate complex scientific concepts effectively. Overall, Dr. Mernyák’s research skills not only span technical synthesis but also encompass interdisciplinary collaboration, project management, and knowledge translation into real-world applications.
Conclusion💡
Dr. Erzsébet Mernyák is a highly deserving candidate for the Best Researcher Award, with significant and sustained contributions to organic and medicinal chemistry. Her pioneering work in synthesizing bioactive molecules with potential therapeutic applications, alongside consistent academic excellence, national recognition, and multidisciplinary collaborations, positions her as a leading figure in Hungarian and European chemical research. With continued momentum, she is likely to play a pivotal role in future drug discovery efforts and academic leadership.
Publications Top Noted✍️
-
Synthesis and investigation of the anticancer effects of estrone-16-oxime ethers in vitro
• Authors: Á. Berényi, R. Minorics, Z. Iványi, I. Ocsovszki, E. Ducza, H. Thole, et al.
• Year: 2013
• Cited by: 80
-
Neighboring group participation: Part 15. Stereoselective synthesis of some steroidal tetrahydrooxazin-2-ones, as novel presumed inhibitors of human 5α-reductase
• Authors: J. Wölfling, L. Hackler, E. Mernyák, G. Schneider, I. Tóth, M. Szécsi, J. Julesz, et al.
• Year: 2004
• Cited by: 65
-
Synthesis and receptor-binding examinations of the normal and 13-epi-D-homoestrones and their 3-methyl ethers
• Authors: J. Wölfling, E. Mernyák, É. Frank, G. Falkay, Á. Márki, R. Minorics, et al.
• Year: 2003
• Cited by: 56
-
Synthesis of Artemisinin–Estrogen Hybrids Highly Active against HCMV, P. falciparum, and Cervical and Breast Cancer
• Authors: T. Fröhlich, A. Kiss, J. Wölfling, E. Mernyák, A. E. Kulmány, R. Minorics, et al.
• Year: 2018
• Cited by: 52
-
Synthesis of trans-16-triazolyl-13α-methyl-17-estradiol diastereomers and the effects of structural modifications on their in vitro antiproliferative activities
• Authors: E. Mernyák, I. Kovács, R. Minorics, P. Sere, D. Czégány, I. Sinka, J. Woelfling, et al.
• Year: 2015
• Cited by: 51
-
Antiproliferative effect of normal and 13-epi-D-homoestrone and their 3-methyl ethers on human reproductive cancer cell lines
• Authors: R. Minorics, N. Bozsity, J. Woelfling, E. Mernyák, G. Schneider, A. Marki, et al.
• Year: 2012
• Cited by: 40
-
Stereoselective synthesis of spiro and condensed pyrazolines of steroidal α, β-unsaturated ketones and nitrilimines by 1,3-dipolar cycloaddition
• Authors: E. Mernyák, E. Kozma, A. Hetényi, L. Márk, G. Schneider, J. Wölfling
• Year: 2009
• Cited by: 40
-
Stereoselective synthesis of some 17β-dihydrooxazinyl steroids, as novel presumed inhibitors of 17α-hydroxylase-C17,20-lyase
• Authors: J. Wölfling, É. A. Oravecz, D. Ondré, E. Mernyák, G. Schneider, I. Tóth, et al.
• Year: 2006
• Cited by: 39
-
Synthesis and biological evaluation of 13α-estrone derivatives as potential antiproliferative agents
• Authors: J. Szabó, Z. Pataki, J. Wölfling, G. Schneider, N. Bózsity, R. Minorics, I. Zupkó, et al.
• Year: 2016
• Cited by: 38
-
Synthesis and structure–activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis
• Authors: I. Bacsa, B. E. Herman, R. Jójárt, K. S. Herman, J. Wölfling, G. Schneider, et al.
• Year: 2018
• Cited by: 37
